Table 2.
Rabbit anti-rPhl p 7 mutant antibodies inhibit patients’ IgE binding to the Phl p 7 wildtype protein.
| Patient | rabbit pre-immune serum (OD 405 nm) | rabbit anti-rPhl p 7 mutant serum (OD 405 nm) | % of inhibition |
|---|---|---|---|
| 1 | 1.677 ± 0.012 | 0.227 ± 0.001 | 86.5 |
| 2 | 1.130 ± 0.026 | 0.255 ± 0.001 | 77.4 |
| 5 | 2.270 ± 0.012 | 0.943 ± 0.057 | 58.5 |
| 6 | 0.851 ± 0.028 | 0.198 ± 0.005 | 76.7 |
| 8 | 1.470 ± 0.027 | 0.327 ± 0.007 | 77.8 |
| 9 | 1.375 ± 0.012 | 0.220 ± 0.003 | 84.0 |
| 12 | 0.740 ± 0.009 | 0.197 ± 0.020 | 73.4 |
| 13 | 0.458 ± 0.017 | 0.141 ± 0.000 | 69.3 |
| N.A. | 0.115 ± 0.004 | 0.158 ± 0.004 | 0 |
ELISA plate-bound rPhl p 7 wildtype was preincubated with 1:100 diluted rabbit anti-rPhl p 7 mutant serum or with the preimmune serum and subsequently exposed to the sera from eight Phl p 7-sensitized patients or from a patient sensitized to an unrelated allergen source (N.A.). IgE binding was measured by ELISA and mean OD values at 405 nm and percentage inhibition of IgE binding is displayed.